< + > Weekly Roundup – August 2, 2025

Welcome to our Healthcare IT Today Weekly Roundup. Each week, we’ll be providing a look back at the articles we posted and why they’re important to the healthcare IT community. We hope this gives you a chance to catch up on anything you may have missed during the week.

The Key to Saving Time in Healthcare? Humanoid Robots. John Lynn interviewed Andrea Thomaz at Diligent Robotics, which learned early on that organizations prefer robots that transport items around the hospital as opposed to keeping stock rooms full. Read more…

Facilitating Payer-Provider Interoperability to Improve Care Coordination. We asked the Healthcare IT Today community what this entails, and expert answers included open data standards, near real-time data access, and targeted patient experiences. Read more…

Innovations Supporting the Transition from Fee-for-Service to Value-Based Payments. Examining patient outcomes, automating administrative tasks, predictive modeling, and supporting care navigation are just some of the suggestions we received from the Healthcare IT Today community about how to make this happen. Read more…

Life Sciences Today Podcast: Intermountain and Civica Rx. This week, John took the microphone and talked to Carter Dredge at Intermountain Health Institute about why Civica Rx is different than traditional life sciences companies and how the partnership is playing out. Read more…

CIO Podcast: Making the Epic Honor Roll. Michael Mainiero at Catholic Health joined John to explain what means to be awarded Epic’s Honor Roll Good Maintenance Grant and what other CIOs can learn by participating in the program. Read more…

Helicopters Shouldn’t Be a Backup Plan for Patient Care. Outbound transfers correlate with higher costs, longer lengths of stay, and worse outcomes. Acute specialty telemedicine, virtual nursing, and AI scribes can eliminate the need for referrals and close these care gaps, said Dr. Chris Gallagher at Access TeleCare. Read more…

TEFCA Enables Interoperability; Now Let’s Make the Data Speak. Data availability alone doesn’t improve care, according to Nate MacLeitch at QuickBlox. AI-powered chatbots, triage tools, and clinical assistants can all help translate shared data into clear, actionable information. Read more…

Shaping the Future of EHR Modernization at University Hospitals. AMCs need EHRs that can support clinical care, research, and training workflows, as well as compliance with privacy and grant-funding requirements. Orgs modernizing their systems would be wise to turn to automation, said Ben Baldi at Tricentis. Read more…

Rethinking Patient Engagement for the Digital Age. Jared Mauskopf at Medical Web Experts and John Deutsch at Bridge described the role of empathy in designing digital health tools to help clinicians listen, explain, and help. Read more…

Smartphones and AI Can Revolutionize Healthcare. While remote monitoring is limited by the cost of equipment and the logistics of getting it into patients’ homes, embedded sensors paid with analytics can power RPM at scale, according to Eric Rock at Percipio Health. Read more…

This Week’s Health IT Jobs for July 30, 2025: Multiple roles in privacy, compliance, and information management. Read more…

Bonus Features for July 27, 2025: Only 40% of generative AI strategies align with business goals, plus USCDI v6 makes its debut. Read more…

Funding and M&A Activity:

• Abacus Group and Medicus IT merged and launched an IT Managed Services Provider (MSP) for the financial services and healthcare industries.
• Life sciences analytics company Sorcero acquired Axiom Health, a real-world data platform.
• AI-powered 3D ultrasound vendor PIUR IMAGING closed a €5.6M growth capital funding round.
• Samsung Electronics acquired Xealth, a platform that combines digital health tools and care programs.
• EHR and workforce automation vendor VitalHub acquired Novari Health, maker of patient flow software.
• Agilio Software completed the acquisition of Blue Stream Academy, provider of healthcare e-learning services.
• Operations software maker symplr acquired AMN Healthcare’s Smart Square Scheduling solution.
• Consulting firm Converge Health launched with a focus on behavioral health, substance use disorder, and SDoH data.

Thanks for reading and be sure to check out our latest Healthcare IT Today Weekly Roundups.

< + > Civica Rx with Carter Dredge – Life Sciences Today Podcast Episode 20

We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. I took over for Danny this episode to sit down with Carter Dredge, Executive Director of the Intermountain Health Institute, to talk about Civica Rx and some of the other unique models that Dredge and his team are working on at Intermountain Health Institute! We kick this episode off by discussing why Intermountain decided to get into the pharma and life sciences business. Then we talk about what makes Civica Rx different from the traditional life sciences companies. Next, we take a look at finances to see what some of the economic dynamics are at play with Civica Rx. Dredge then shares with us some examples of the impact of this work. Then Dredge walks us through what life sciences should understand about Civica’s efforts.

We’ve heard rumors that Intermountain is starting something big in the healthcare innovation space – so we ask Dredge to give us a little teaser of what that is, its purpose, and when we should be expecting it. Then we dig into Dredge’s use of the phrase ‘healthcare utility’ to learn more about what that is and how it will influence the future of healthcare. Finally, we conclude this episode with Dredge sharing more about the publications he’s done with Cambridge Judge Business School, Professor Stefan Scholtes.

Here’s a list of some of the publications mentioned:

• Changing the Script on Drug Pricing
• Disruptive Collaboration
• The Health Care Utility Model (HCU)
• Vaccinating Health Care Supply Chains Aginst Market Failure

Check out the main topics of discussion for this episode of the Life Sciences Today podcast:

• Why did Intermountain decide to get into the pharma and life sciences business?
• What makes Civica Rx different than a traditional life sciences company?
• What are the economic dynamics at play with Civica Rx?
• Can you give us some examples of the impact of this work?
• What should life sciences understand about Civica’s efforts?
• I hear you are starting something big in the healthcare innovation space. Can you give us a little teaser of what that is, and its purpose and timeline?
• You’ve often used the phrase ‘Healthcare Utility’. Can you tell us a little more about what that is and how it will influence the future of healthcare?
• Tell us more about your publications that you’ve done with Cambridge Judge Business School, Professor Stefan Scholtes.

Now, without further ado, we’re excited to share with you the next episode of the Life Sciences Today podcast.

Be sure to subscribe to the Life Sciences Today on your favorite podcasting platform:

• Apple Podcasts
• Spotify
• iHeartRadio
• Amazon Music
• Pandora
• YouTube

Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube.  Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.

If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.

Thanks so much for listening!

< + > Abacus and Medicus IT Merge, Creating The Leading Financial Services and Healthcare-Focused IT Managed Services Platform

Merger Demonstrates FFL Partners’ IT Services Expertise and Successful Sector Exploration and Expertise Development (SEED) Strategy

FFL Partners (FFL), a private equity firm focused on growth investments in tech-enabled business services and healthcare companies, today announced the completion of the merger of FFL portfolio companies Abacus Group and Medicus IT to launch a new multi-vertical IT Managed Services Provider (MSP) exclusively focused on the financial services and healthcare industries. Financial terms of the transaction were not disclosed.

“We have seen significant demand from both prospective clients and investors for IT MSPs that are vertical experts in sectors where compliance and cybersecurity are paramount,” said Jonathon Bunt, Partner at FFL. “By bringing together Abacus, the leading financial services-focused MSP, and Medicus IT, the leading healthcare-focused MSP, we are excited to create a financial services and healthcare-focused MSP powerhouse that can help compliance-focused clients achieve everything they need from an IT, cybersecurity, data, and AI perspective.”

“The combination of Abacus and Medicus enables us to further scale our global suite of managed services across IT operations, multi-cloud, cybersecurity, devops, tech-enablement, and AI capabilities to better serve our clients,” said Anthony J. D’Ambrosi, CEO at Abacus, who will lead the newly combined business. “We are thrilled to partner with Medicus’ talented team, who bring deep healthcare IT industry expertise, along with a compliance-oriented mindset, to the combined company and share our enthusiasm and vision for serving clients and growing the business.”

“FFL has been an outstanding partner to both of our companies, and we believe this merger marks the start of an exciting new chapter for our combined organization,” said Chris Jann, Founder and CEO at Medicus IT. “For Medicus, this combination unlocks meaningful growth opportunities and expands the depth and the breadth of technology, data, and cybersecurity service offerings that we can deliver to our healthcare clients. As the healthcare compliance and cybersecurity environment grows more complex, we are uniquely positioned to empower our clients to thrive, protect their organizations, and lead with confidence in the face of change.”

“This merger validates our long-term focus on IT MSPs that began in 2019 when our proprietary Sector Exploration and Expertise Development (SEED) value creation strategy identified vertically specialized IT MSPs as an attractive area for investment. This transaction is a win-win for Abacus and Medicus, providing the opportunity to expand the total addressable market and accelerate growth across both end markets, organically and inorganically,” added Cas Schneller, Managing Partner at FFL.

FFL has strong experience investing in and growing outsourced IT services businesses through strategic acquisitions and organic growth initiatives. Past investments include ALKU, an Andover, Mass.-based IT & Life Sciences consulting firm, and Optomi Professional Services, a specialized provider of IT staffing, managed services, and professional services.

About FFL Partners

FFL Partners is a leading middle-market private equity firm that has been investing in high-quality companies since 1997. Based in San Francisco, FFL is a hyperspecialized, thematic investor focused on targeted areas where the firm has deep expertise and broad networks. FFL employs a proprietary sourcing and value creation strategy called the Sector Exploration and Expertise Development (SEED) process. The firm aims to partner with exceptional management teams and employs a high-engagement approach to accelerate growth at its businesses. FFL currently has over $6 billion of cumulative capital commitments. For additional information, please visit fflpartners.com

About Abacus Group

Abacus Group is a global managed IT and cybersecurity service provider specializing in the unique needs of the financial services industry. With deep expertise in multi-cloud, compliance, and IT-as-a-Service solutions, Abacus Group enables firms to operate securely, efficiently, and at scale.

The innovative and award-winning multi-cloud abacusFlex platform delivers all technology and security needs as a service, empowering clients to meet evolving cybersecurity, regulatory compliance, and infrastructure requirements.

Abacus Group supports clients across global financial markets, with dual headquarters in New York and London. For more information, visit abacusgroupllc.com.

About Medicus IT

Medicus IT is committed to helping healthcare organizations leverage technology to optimize patient care and deliver better patient outcomes. Moving beyond traditional IT, Medicus helps its healthcare clients run their IT infrastructure, grow their operations, and transform their organizations. Headquartered in Alpharetta, Georgia, with service centers in New Jersey, Ohio, Florida, Arizona, California, and North Carolina, Medicus is one of the nation’s top healthcare IT providers, serving over 6,500 providers, with more than 50,000 users across 2,500 locations. Follow us on X, LinkedIn, and Facebook.

Together, we drive healthcare forward.

Originally announced July 15th, 2025

< + > Sorcero Acquires Axiom Health to Bring Together AI-Driven Insights Across Life Sciences and Medical Device Markets

Company Announces Launch of Sorcero MedTech

Sorcero, a leader in AI-powered analytics for life sciences companies, today announced its acquisition of Axiom Health, a real-world data platform focused on the medical technology industry. The Axiom Health platform becomes Sorcero MedTech, enabling the Sorcero Intelligence Platform to become the first unified AI platform for both pharmaceutical and medical device organizations, addressing the growing demand for real-time insights across healthcare.

By integrating the former Axiom Health MedTech industry data lake with The Sorcero Intelligence Platform, Sorcero will now provide life sciences organizations with broader visibility into new market opportunities and improved patient outcomes.

“The integration of pharmaceutical and medical device data unlocks critical insights that have been siloed for too long,” said Dipanwita Das, CEO at Sorcero. “For the first time, life sciences teams can see the complete patient journey across drugs and devices to understand treatment pathways holistically and make informed decisions about product development and commercialization. This unified view will accelerate innovation and deliver better patient outcomes.”

Sorcero’s acquisition also extends its reach into the global MedTech market, which is valued at $595 billion, according to Medical Product Outsourcing. Now, with the industry’s first medical and commercial intelligence platform across drugs and devices, Sorcero strengthens its position as the vendor of choice for life sciences companies. The enhanced platform enables:

• Cross-vertical analysis spanning pharma, medical device, and stakeholder data
• Rapid AI-powered insights on product development and commercialization
• Complete understanding of the patient journey
• Stakeholder micro-targeting to understand exactly why, how, and when their product is being used, across medical devices and pharmaceutical portfolios
• Enhanced market intelligence for targeted decision-making and commercial strategy

“By combining Axiom Health’s market-leading medtech data with Sorcero’s AI platform, we can now provide a single source of truth delivering unified device and drug insights for medical and commercial teams,” said A. Krishna, Founder and President of Axiom Health, who now becomes Senior Vice President of MedTech at Sorcero. “I look forward to enabling our MedTech customers to personalize engagement and drive measurable impact with physicians and KOLs, powered by Sorcero’s global data across stakeholders, scientific sentiment, and deeper insights into unmet patient needs.”

The transaction was supported by a new investment from First Trust Capital Partners, LLC and other Axiom investors.

“We believe this strategic combination creates a differentiated platform positioned at the intersection of AI innovation and healthcare delivery,” said Jon Phillips, First Trust Capital Partners Managing Director. “The integration of medical device commercial intelligence with Sorcero’s established pharmaceutical analytics platform addresses a critical market need while opening significant growth opportunities in the expanding life sciences AI market. We’re excited to support this transformation that we believe will help reshape how the industry leverages data to improve patient care.”

To learn more about Sorcero, visit sorcero.com.

About Sorcero

Sorcero is a leading provider of AI-powered solutions for the life sciences industry, dedicated to improving patient outcomes through innovative technology. By combining advanced natural language processing with domain-specific expertise, Sorcero develops tools that transform how healthcare and pharmaceutical professionals access and utilize critical information. The company’s innovation has been recognized by over a dozen awards, including Fast Company’s Most Innovative Companies of 2024, and six foundational medical AI patents. Learn more at sorcero.com.

Originally announced July 15th, 2025